Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Phreesia's change in inventory for the quarter that ended in Jul. 2026 was $0.0 Mil. It means Phreesia's inventory
stayed the same
from Apr. 2026 to Jul. 2026 .
Phreesia's change in inventory for the fiscal year that ended in Jan. 2026 was $0.0 Mil. It means Phreesia's inventory
stayed the same
from Jan. 2025 to Jan. 2026 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Phreesia's Days Inventory for the quarter that ended in Jul. 2026 was 0.00.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Phreesia's Inventory-to-Revenue for the quarter that ended in Jul. 2026 was 0.00.
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Phreesia's Inventory to Revenue for the quarter that ended in Jul. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phreesia Change In Inventory Related Terms
Phreesia Change In Inventory Historical Data
* Premium members only.
The historical data trend for Phreesia's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Jul. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phreesia (LTS:0A23) has a Change In Inventory of $0.0 Mil as of Jul. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Phreesia and its competitors.
Is Phreesia's Change In Inventory too high?
Phreesia's current Change In Inventory is $0.0 Mil. Overall, Phreesia has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Phreesia's Change In Inventory compare to SOPH and CTEV?
Phreesia's Change In Inventory of $0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Healthcare Providers & Services company?
A good Change In Inventory depends on the Healthcare Providers & Services industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Phreesia and its competitors. Phreesia's current Change In Inventory is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phreesia stock overvalued right now?
Phreesia (LTS:0A23) has a current Change In Inventory of $0.0 Mil. The stock's GF Value™ is $67.52, compared to a current price of $28.50 — trading 57.8% below its estimated fair value. The current Change In Inventory is $0.0 Mil. Phreesia's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Phreesia (LTS:0A23), the current Change In Inventory is $0.0 Mil as of Jul. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Phreesia (LTS:0A23) Overvalued in 2026?
Based on GuruFocus' analysis, Phreesia stock appears to be undervalued.
The current stock price of $28.50 is trading 57.8% below its estimated GF Value™ of $67.52.
Key valuation signals for LTS:0A23:
Change In Inventory: $0.0 Mil
GF Value™: $67.52 vs. price of $28.50 (57.8% below fair value)
No single metric tells the full story. See the LTS:0A23 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
66GF Score
Get the complete analysis for LTS:0A23
Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0A23 has been successfully added to your 
